Saikat Nandi

Seasoned investment executive, business operator and entrepreneur with over 20 years of buy-side and C-level management experience in healthcare, technology and financial services industries. Has managed public and private investments totaling more than $1 billion and has helped build over 20 life science and technology companies. Served on the Board of Directors of Atomwise, Cullinan Oncology (NASDAQ: CGEM), ElevateBio, Fractyl Health, Roivant Sciences (NASDAQ: ROIV), SQZ (NYSE: SQZ). Serves as Strategic Advisor & Investment Mentor for New York State Incubator & Vanderbilt University Accelerator. As Global Chief Business Officer at Oryzon, managed cross-functional teams across financing, M&A, business development and operations. As Portfolio Manager at AIG Asset Management, oversaw AIG’s healthcare & life sciences investments across venture capital, private equity, hedge fund and debt securities. Previously served as Healthcare Investment Advisor at a global multi-family office managing venture and growth equity investments and prior to that served as Business Development Consultant at the New York State Center for Biotechnology, overseeing strategic partnerships and capital raising activities. Holds a Visiting Scientist position at the Cold Spring Harbor Laboratory (CSHL) and serves as reviewer & board member of several portfolio companies, federal funding agencies, scientific journals & philanthropic organizations. Received D.Phil. (Ph.D.) from Oxford University & several awards, honors & research grants. Authored over two dozen articles & books. Multilingual, avid dog lover and has lived and worked in North America, Europe and Asia.